STAT+: Here’s who might replace Francis Collins as NIH director
WASHINGTON — Almost as soon as Francis Collins announced that he’ll soon step down as…
Category: Politics
.jpg)
NIH Director Francis Collins to step down
WASHINGTON — Francis Collins, the pioneering genetics researcher and longtime director of the National Institutes…
STAT+: Biden administration favors insurers over doctors in controversial new surprise billing regulations
WASHINGTON — The Biden administration on Thursday sided with insurers over physicians and other health…
STAT+: Key Senate committee considers a carveout for small biotech companies in drug pricing reforms
WASHINGTON — A key Senate panel is seriously considering a new policy that would soften…
The government’s Covid-19 response will continue in a shutdown, but health agencies will face major staff shortages
A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
STAT+: Big business lobbies bitterly divided over drug pricing reform
WASHINGTON — Groups representing companies like Apple, Tesla, and Boeing are clashing with Washington’s wealthiest…
STAT+: In May, 10 moderate Democrats opposed major drug pricing reform. Ahead of a key vote, that list is shrinking
WASHINGTON — Ten House Democrats fired a warning shot in the spring that they could…
Biden’s chaotic messaging on Covid-19 boosters is pitting the White House against the government’s scientific advisers
WASHINGTON — The White House’s chaotic, contradictory messaging on Covid-19 vaccine booster shots has given…
See how much Covid-19 relief money health care providers in your state got
Congress set up a massive, $178 billion fund in 2020 meant to help mitigate the…
STAT+: Senate proposes expanding pharma penalties for hiking drug prices
WASHINGTON — A key Senate panel is expanding its plans to punish drug makers that…
STAT+: ‘A solid black eye’: Drug pricing reform advocates scramble to reset after setback in Congress
WASHINGTON — For the cadre of progressive groups fighting to bring down drug prices in…
STAT+: Drug makers failed to block House provision cracking down on orphan drug tax credits
WASHINGTON — Drug makers mounted a last-minute, and so far unsuccessful, campaign to kill a surprise…
Moderate Democrats sink Pelosi’s aggressive drug pricing bill in key committee vote
WASHINGTON — House Speaker Nancy Pelosi’s aggressive drug pricing package failed a key committee vote…
Virtual Event: The 340B drug discount program is at a crossroads. What’s next?
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Key senator opposes Democrats’ target for drug-pricing savings
WASHINGTON — An influential Senate Democrat is pushing back against his party’s efforts to cut…
House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain
WASHINGTON — Three moderate House Democrats are making good on their threat to oppose Speaker…
Biden administration releases $25 billion in Covid relief for providers after months of delay
WASHINGTON — The Biden administration on Friday announced plans to release more than $25 billion to…
FDA misses deadline for deciding which e-cigarette products should be removed from the market
WASHINGTON — The Food and Drug Administration announced Thursday that it has failed to meet…
STAT+: Senate considers pegging Medicare drug prices to deeply discounted Veterans Affairs rates
WASHINGTON — Senate lawmakers are actively considering pegging the prices Medicare pays for drugs to…
STAT+: The FDA has just 3 days to decide how to regulate 6.5 million e-cigarette products. But what if it blows past the deadline?
WASHINGTON — The Food and Drug Administration has just three days until it must finally…
STAT+: Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
WASHINGTON — As Democrats design a way to use the government’s leverage to lower drug…
The White House wants $65 billion for an Apollo-style pandemic preparedness program
WASHINGTON — The Biden administration on Friday unveiled a sweeping new biosecurity plan, outlining a…
Congress demands documents from FDA on controversial approval of Biogen’s Alzheimer’s drug
WASHINGTON — Lawmakers have requested data and documents from the Food and Drug Administration related…
STAT+: The 10 power players to watch on Democrats’ drug pricing push
WASHINGTON — In the coming weeks, Democrats will embark on an ambitious effort to change…
Biden pledged to ‘follow the science.’ But experts say he’s sometimes fallen short
WASHINGTON — It’s a mantra that President Biden has repeated since the early days of…
How one vape shop is openly defying FDA regulations
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
STAT+: Two top FDA officials in charge of Covid-19 vaccines to leave agency this fall
WASHINGTON — The two officials in charge of leading the FDA’s review of coronavirus vaccine…
STAT+: ‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby
WASHINGTON — The Biotechnology Innovation Organization, the lobbying group that represents roughly 1,000 biotech companies,…
STAT+: Biden health department hires four outside firms to audit Covid-19 grants to hospitals
WASHINGTON — The Biden administration has hired several separate outside contractors to police the billions…
STAT+: FDA, drug makers propose new pilots aimed at speeding rare disease drugs, as part of user fee update
WASHINGTON — The Food and Drug Administration and the drug industry have jointly agreed to…
STAT+: Ellis Unger, an outspoken FDA veteran, resigns
WASHINGTON — A top FDA official known for speaking out against controversial drug approval decisions,…
In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices
President Biden on Thursday took his most concrete action to date on prescription drug prices,…
STAT+: Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices
WASHINGTON — Five of the most vulnerable Democrats in the Senate on Tuesday publicly renewed…
STAT+: Will controversy over new Alzheimer’s drug spell the end for the FDA’s faster approval process?
WASHINGTON — For most of its history, the Food and Drug Administration’s shortcut pathway for…
Desperate for relief amid Covid-19, hospitals find an unusual ally in Susan Collins
WASHINGTON — The lobbying frenzy began late last month, as senators and the White House…
Billions in new research funding sparks a lobbying frenzy among patient advocates
WASHINGTON — President Biden’s vision for an ambitious new government research center is never quite…
STAT+: Congress presses the FDA to move faster on ALS drugs
WASHINGTON — Lawmakers pressed a top Food and Drug Administration official Thursday for answers on…
STAT+: Hospitals and pharma are both on the hook to help fund infrastructure deal
WASHINGTON — Both hospitals and drug makers are on the hook to help pay for…
STAT+: San Francisco, Austin, or Raleigh? White House contemplates an out-of-D.C. address for new biomedical research agency
WASHINGTON — The White House isn’t worried about Congress underfunding the new biomedical research agency…
STAT+: Pharma CEOs, lobbyists showered Democrat with cash after his attempt to torpedo Pelosi’s drug pricing bill
WASHINGTON — The very next day after Rep. Scott Peters attempted to torpedo House Speaker…
NIH’s Francis Collins: For Biden’s new research agency to succeed, it should prepare for some projects to fail
WASHINGTON — Francis Collins is ready for the National Institutes of Health to fail spectacularly….
STAT+: The ins and outs of the rare, controversial way Medicare might pay for Biogen’s new Alzheimer’s drug
WASHINGTON — The Food and Drug Administration last month foisted a nearly impossible decision on…
STAT+: Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal
WASHINGTON — Senate Democrats intend to include several drug pricing policies in their $3.5 trillion…
FDA chief Janet Woodcock acknowledges agency may have misstepped in process leading up to Alzheimer’s drug approval
WASHINGTON — Acting Food and Drug Administration Commissioner Janet Woodcock acknowledged on Wednesday her agency…
Biden to nominate West Virginia’s Rahul Gupta as drug czar
WASHINGTON — President Biden will nominate Rahul Gupta, a March of Dimes executive and former…
When and how will we know if we need Covid-19 booster shots?
There’s a lot we don’t yet know about the data behind Pfizer and BioNTech’s renewed…
STAT+: Medicare starts process that could limit access to Biogen’s new Alzheimer’s drug
WASHINGTON — Federal officials on Monday announced the agency will start a process that could…
Powerful House Democrats demand documents from Biogen about coordination with FDA on new Alzheimer’s drug
WASHINGTON — Two powerful House Democrats on Monday demanded documents from Biogen about the approval…
Experts warn full Covid-19 vaccine approval is no quick fix for hesitancy
WASHINGTON — The Food and Drug Administration issuing full approval for two Covid-19 vaccines might…
STAT+: In a sweeping executive order, Biden endorses importing drugs from Canada and orders a bigger drug pricing plan by late August
WASHINGTON — President Biden on Friday will take aim at the pharmaceutical industry by ordering…